These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35257190)

  • 1. [Chemotherapy and targeted therapy of head and neck squamous cell carcinomas at the 2021 ASCO meeting].
    Blaurock M; Busch CJ
    HNO; 2022 Apr; 70(4):265-270. PubMed ID: 35257190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Main results of studies on primary therapy of head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2014].
    Gliese A; Busch CJ; Knecht R
    HNO; 2014 Nov; 62(11):781-6. PubMed ID: 25274201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
    Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
    BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
    Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kwon JH; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
    BMC Cancer; 2020 Aug; 20(1):813. PubMed ID: 32854649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial.
    Guo Y; Luo Y; Zhang Q; Huang X; Li Z; Shen L; Feng J; Sun Y; Yang K; Ge M; Zhu X; Wang L; Liu Y; He X; Bai C; Xue K; Zeng Y; Chang X; Chen W; Lin T
    Eur J Cancer; 2021 Oct; 156():35-45. PubMed ID: 34418665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2019 ASCO Meeting].
    Zech HB; Laban S; Schafhausen P; Bussmann L; Betz C; Busch CJ
    HNO; 2019 Dec; 67(12):898-904. PubMed ID: 31701170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life analysis of patients treated with cetuximab or cisplatin for locoregionally advanced squamous cell carcinoma of head and neck in the United States.
    Aggarwal H; Punekar RS; Li L; Carter GC; Walker MS
    Health Qual Life Outcomes; 2020 Jun; 18(1):195. PubMed ID: 32571349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial.
    Keil F; Hartl M; Altorjai G; Berghold A; Riedl R; Pecherstorfer M; Mayrbäurl B; De Vries A; Schuster J; Hackl J; Füreder T; Melchardt T; Burian M; Greil R
    Eur J Cancer; 2021 Jul; 151():201-210. PubMed ID: 34022697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.
    Oppelt P; Ley J; Daly M; Rich J; Paniello R; Jackson RS; Pipkorn P; Liu J; Gay H; Palka K; Neupane P; Powell S; Spanos WC; Gitau M; Zevallos J; Thorstad W; Adkins D
    Med Oncol; 2021 Mar; 38(4):35. PubMed ID: 33683482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial.
    Elbers JBW; Al-Mamgani A; Tesseslaar MET; van den Brekel MWM; Lange CAH; van der Wal JE; Verheij M; Zuur CL; de Boer JP
    Radiother Oncol; 2020 Jan; 142():79-84. PubMed ID: 31563412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
    Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak AR; Chen EX; Jang R; O'Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR
    Invest New Drugs; 2016 Oct; 34(5):575-83. PubMed ID: 27289242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700).
    Merlano MC; Denaro N; Vecchio S; Licitra L; Curcio P; Benasso M; Bagicalupo A; Numico G; Russi E; Corvo' R; Bruzzi P;
    Oncology; 2020; 98(11):763-770. PubMed ID: 32629446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.
    Harari PM; Harris J; Kies MS; Myers JN; Jordan RC; Gillison ML; Foote RL; Machtay M; Rotman M; Khuntia D; Straube W; Zhang Q; Ang K
    J Clin Oncol; 2014 Aug; 32(23):2486-95. PubMed ID: 25002723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
    Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
    Johnson KCC; Ley J; Oppelt P; Lu J; Gay HA; Daly M; Jackson R; Rich J; Pipkorn P; Paniello RC; Zevallos J; Thorstad W; Adkins DR
    Med Oncol; 2019 Oct; 36(11):93. PubMed ID: 31595355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types).
    Nouman M; Haider G; Bukhari N; Yousuf A; Nouman R; Shaikh MR; Hussain S; Pavan B; Rahool R; Memon P; Zahoor S; Mehar K; Sami A
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):825-830. PubMed ID: 32212813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab.
    Granados-García M; Aguilar-Ponce JL; Maldonado-Magos F; De la Garza-Salazar JG
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):320-333. PubMed ID: 28125819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on radiotherapy of head and neck cancer : Highlights of the 2019 ASCO Annual Meeting].
    Ott S; Wiegel T; Hoffmann TK; Petersen C; Tribius S; Laban S
    HNO; 2019 Dec; 67(12):918-924. PubMed ID: 31659379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy in Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma. Cetuximab is Inferior to Cisplatin - is the Case now Closed?
    Donnelly O; Kelly C; Iqbal MS
    Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):783-785. PubMed ID: 35945073
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.
    Fury MG; Xiao H; Sherman EJ; Baxi S; Smith-Marrone S; Schupak K; Gewanter R; Gelblum D; Haque S; Schoder H; Shah JP; Katabi N; Kurtzman R; Lipson B; Cox L; Lee NY; Pfister DG
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E566-70. PubMed ID: 25784616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.